20 completed, 6 terminated, 4 unknown, 3 recruiting. 15 Phase 2, 11 Phase 3, 5 Phase 4, 4 Not applicable, 4 Phase 1.
Follow EPO: new trials by email Literature Review of EPO trials Research Report on EPO
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial) Biospecimen Collection, Bone Marrow Aspiration, Emavusertib - Myelodysplastic Syndrome | Phase 2 | Not yet recruiting | National Cancer Institute (NCI) | 270 | 2026-12-18 | 2026-09-22 |
| Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients. Erythropoietin + Probiotic, EPO - Anaemia, Chronic Kidney Disease | Phase 3 | Completed | Badr University | 80 | 2026-02-01 | 2026-10-30 |
| EVR and EPO for Liver Transplant Tolerance Everolimus, Epoetin alfa - Liver Transplant | Phase 1 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | 2026-01-21 | 2026-04-06 |
| Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial Iron, EPO, 0.9 % NaCl - Anemia, Sepsis | Phase 4 | Recruiting | Piotr Czempik | 200 | 2024-11-10 | 2024-12-27 |
| MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) Allogeneic Hematopoietic Stem Cell Transplantation, Azacitidine, Best Practice - Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | Phase 2 | Recruiting | National Cancer Institute (NCI) | 2000 | 2024-06-18 | 2026-11-02 |
| Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT decitabine, umbilical cord blood, Granulocyte-colony stimulating factor - Poor Graft Function | Phase 3 | Not yet recruiting | The First Affiliated Hospital of Soochow University | 100 | 2023-08-01 | 2023-06-09 |
| Decitabine for Poor Graft Function Post Allo-HSCT Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist - Poor Graft Function | Phase 3 | Completed | The First Affiliated Hospital of Soochow University | 76 | 2023-07-01 | 2026-10-23 |
| Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients Erythropoietin - Liver Transplant Rejection | Phase 4 | Completed | Northwestern University | 9 | 2022-02-18 | 2026-10-29 |
| Practical Anemia Bundle for SusTained Blood Recovery Iron Dextran, Erythropoietin (EPO) - Anemia, Critical Illness | Phase 2 | Completed | Mayo Clinic | 100 | 2021-11-30 | 2025-04-06 |
| Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma recombinant human erythropoietin - Lymphoma, Anemia | Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 130 | 2021-04-01 | 2021-08-11 |
| Mechanisms of EPO-induced Hypertension Darbepoetin - Chronic Kidney Disease, Blood Pressure | Phase 2 | Terminated | VA Office of Research and Development | 27 | 2021-01-04 | 2025-12-15 |
| The Effect of Micro-doses Erytropoietin on Exercise Capacity in Male and Females EPO, Control group - saline injection - Sports Drug Abuse | Not applicable | Unknown | University of Copenhagen | 48 | 2019-08-28 | 2023-11-29 |
| Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients Umbilical cord blood infusion, Erythropoietin injection, Placebo umbilical cord blood infusion - Stroke, Umbilical Cord Blood | Phase 1 / Phase 2 | Unknown | Bundang CHA Hospital | 24 | 2019-05-02 | 2020-11-05 |
| Erythropoietin in Hemolytic Uremic Syndrome erythropoietin - Hemolytic-Uremic Syndrome, Anemia | Phase 4 | Completed | Hospital General de Niños Pedro de Elizalde | 24 | 2019-01-01 | 2021-01-13 |
| Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders Erythropoietin, Saline - Bipolar Disorder, Cognitive Impairment | Phase 2 | Completed | Lars Vedel Kessing | 103 | 2017-07-05 | 2023-03-16 |
| Effects of Erythropoietin for Cognitive Side-effects of ECT Erythropoietin, Saline - ECT, Cognitive Impairment | Phase 2 | Completed | Martin Balslev Jørgensen | 60 | 2017-06-26 | 2023-09-21 |
| The Prevention of Erythropoietin on Cardiac Surgery-associated Acute Kidney Injury Erythropoietin, 0.9% sodium chloride, cardiac surgery - Acute Kidney Injury, Cardiac Disease | Not applicable | Terminated | Nanjing First Hospital, Nanjing Medical University | 101 | 2015-10-01 | 2023-01-26 |
| Erythropoietin in Premature Infants to Prevent Encephalopathy Epo, Normal saline - Premature Infant | Phase 2 | Terminated | Children's Hospital of Fudan University | 58 | 2015-09-08 | 2023-12-29 |
| Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis EPO, Normal saline - Premature Infant | Phase 2 | Completed | Zhengzhou University | 1285 | 2014-01-01 | 2019-04-19 |
| Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) Epo, Control - Extreme Prematurity | Phase 3 | Completed | University of Washington | 941 | 2013-12-01 | 2026-05-19 |
Showing 20 of 36. Sign in to see all of them.
Anemia (11) · Myelodysplastic Syndromes (5) · Premature Birth (4) · Bipolar Disorder (3) · Cognitive Dysfunction (2) · Depression (2) · Depressive Disorder (2) · Renal Insufficiency, Chronic (2) · Acute Kidney Injury (1) · Anemia, Iron-Deficiency (1) · Anemia, Refractory (1) · Asphyxia (1) · Brain Injuries (1) · Cardiovascular Diseases (1) · Cerebral Palsy (1)
National Cancer Institute (NCI) (3) · The First Affiliated Hospital of Soochow University (2) · Zhengzhou University (2) · ARCAGY/ GINECO GROUP (1) · American Regent, Inc. (1) · Badr University (1) · Bundang CHA Hospital (1) · Children's Hospital of Fudan University (1) · Eastern Cooperative Oncology Group (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Gynecologic Oncology Group (1) · Hospital General de Niños Pedro de Elizalde (1) · Larry Cripe, MD (1) · Lars Vedel Kessing (1) · Lars Vedel Kessing, professor, MD, DMSc. (1)
United States (12) · China (8) · Denmark (4) · Canada (2) · France (2) · Argentina (1) · Austria (1) · Egypt (1) · Poland (1) · Puerto Rico (1) · South Korea (1) · Spain (1)
Kamilla W. Miskowiak, Prof. (2) · Alejandro Balestracci, MD, PhD (1) · Amit K Verma (1) · Changchun Cao, Doctor (1) · Changlian Zhu, MD, PhD (1) · Changlian Zhu, PhD (1) · Gillian Thomas (1) · Jerald P Radich (1) · Josh Levitsky, MD (1) · Karen E Yeates, MD, FRCP(C), MPH (1) · Kenneth B. Miller, MD (1) · Larry Cripe, M.D. (1) · Lars V Kessing, Professor (1) · Lars V. Kessing, Prof. (1)
PMID 33076939, PMID 16818281, PMID 18404143, PMID 19564636, PMID 20942940, PMID 21420732, PMID 22098110, PMID 22305837, PMID 22353604, PMID 25099079, PMID 25641635, PMID 26011424, PMID 26181032, PMID 26996196, PMID 27057344, PMID 27088376, PMID 27195774, PMID 27259062, PMID 27835716, PMID 28821985, PMID 29673379, PMID 30400939, PMID 31804779, PMID 31940698, PMID 32488672, PMID 32771013, PMID 32804205, PMID 33113526, PMID 33439748, PMID 33646303, PMID 34117080, PMID 34324880, PMID 34492685, PMID 34845352, PMID 35166922, PMID 35338252, PMID 35725917, PMID 35853728, PMID 36317927, PMID 36460332, PMID 36580332, PMID 36902217, PMID 37095637, PMID 37561461, PMID 37790304, PMID 37926336, PMID 38128460, PMID 38195921, PMID 38195922, PMID 38227447
2016 (2), U10CA021115 (2), 2009 (1), K23HL153310 (1), R01NR008937 (1), U01NS077953 (1), U10CA027469 (1), U10CA180820 (1), U10CA180863 (1), U10CA180888 (1), U24CA196172 (1)